Ustekinumab biosimilar(Bioceros)

N/A

Report date: 2025/03/07 17:34:29

Base Information

Drug NameUstekinumab biosimilar(Bioceros)
Drug Alias NameBOW-090PB-007
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Biosimilar
Mechanisms of ActionInterleukin-12 inhibitorsInterleukin-23 inhibitors
TargetsInterleukin-12Interleukin-23
Therapy Area/IndicationsPlaque psoriasisCrohn DiseaseArthritis, Psoriatic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBioceros
China Registration ClassN/A

Develop Information

Active CompaniesBioceros
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisCrohn DiseaseArthritis, Psoriatic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A